Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

PRQR

ProQR Therapeutics N.V

May 11 • 04:00PM ET

1.61

+0.03 1.90 %

Healthcare • Biotechnology • Netherlands • Micro • NASD

Peers: WVE QURE ARWR EDIT VYGR

| Held by: QQQS

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.45	Insider Own	32.21%	Shs Outstand	103.01M	Perf Week	-1.83%
Market Cap	169.63M	Forward P/E	-	EPS next Y	-0.70	Insider Trans	0.00%	Shs Float	71.43M	Perf Month	-12.97%
Enterprise Value	77.53M	PEG	-	EPS next Q	-0.14	Inst Own	36.08%	Short Float	1.18%	Perf Quarter	9.52%
Income	-47.66M	P/S	9.47	EPS this Y	-25.74%	Inst Trans	-1.04%	Short Ratio	1.54	Perf Half Y	-27.15%
Sales	17.91M	P/B	2.86	EPS next Y	-18.68%	ROA	-31.11%	Short Interest	0.84M	Perf YTD	-20.30%
Book/sh	0.56	P/C	1.56	EPS next 5Y	11.29%	ROE	-63.67%	52W High	3.10 -48.06%	Perf Year	0.00%
Cash/sh	1.03	P/FCF	-	EPS past 3/5Y	21.80% 15.68%	ROIC	-68.87%	52W Low	1.33 21.05%	Perf 3Y	-19.90%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	68.13% -	Gross Margin	82.95%	Volatility	8.69% 8.46%	Perf 5Y	-75.08%
Dividend TTM	-	EV/Sales	4.33	EPS Y/Y TTM	-30.17%	Oper. Margin	-276.57%	ATR (14)	0.14	Perf 10Y	-67.21%
Dividend Ex-Date	-	Quick Ratio	3.09	Sales Y/Y TTM	-12.37%	Profit Margin	-266.13%	RSI (14)	47.11	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	3.09	EPS Q/Q	1.95%	SMA20	-4.78%	Beta	0.07	Target Price	9.04
Payout	-	Debt/Eq	0.28	Sales Q/Q	18.77%	SMA50	-4.73%	Rel Volume	1.08	Prev Close	1.58
Employees	-	LT Debt/Eq	0.19	Earnings	Mar 12 BMO	SMA200	-19.31%	Avg Volume	549.61K	Price	1.61
IPO	Sep 18, 2014	Option/Short	Yes / Yes	EPS/Sales Surpr.	-0.58% -16.17%	Trades		Volume	576,134	Change	1.90%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)